InvestLog
CRNX Crinetics Pharmaceuticals, Inc. logo

CRNX Crinetics Pharmaceuticals, Inc.

Healthcare
$36.80-0.78%ClosedMarket Cap: $3.88B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

3

Dispositions

4

Buy/Sell Ratio

0.75

Net Shares

-85,163

Shares Acquired

78,434

Shares Disposed

163,597

Total Bought ($)

$0.00

Total Sold ($)

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Apr 10Knight Jeff E.officer: Chief Dev. & Operating OfficerSell85,163$40.10105,289
Fri Apr 10Knight Jeff E.officer: Chief Dev. & Operating OfficerSell49,474$23.98161,492
Fri Apr 10Knight Jeff E.officer: Chief Dev. & Operating OfficerSell19,336$19.64190,452
Fri Apr 10Knight Jeff E.officer: Chief Dev. & Operating OfficerSell9,624$20.02171,116
Wed Mar 18Struthers Richard Scottdirector, officer: President & CEOSell13,196$37.11413,563
Wed Mar 18Struthers Richard Scottdirector, officer: President & CEOSell8,785$37.77404,778
Wed Mar 18Knight Jeff E.officer: Chief Operating OfficerSell5,950$37.11115,979
Wed Mar 18Knight Jeff E.officer: Chief Operating OfficerSell3,961$37.77112,018
Wed Mar 18Betz Stephen F.officer: Chief Scientific OfficerSell6,371$37.11141,342
Wed Mar 18Betz Stephen F.officer: Chief Scientific OfficerSell4,241$37.77137,101
Fri Mar 13Vivaldi Coelho RogeriodirectorSell4,477$36.0816,823
Fri Mar 13Vivaldi Coelho RogeriodirectorSell523$36.7716,300
Wed Mar 04Schilke Tobinofficer: Chief Financial OfficerSell6,713$39.6778,121
Wed Mar 04Okey StephaniedirectorSell3,000$39.6713,300